Pressemitteilungen von Aji Bio-Pharma Pressemitteilungen June 30, 2020 Ajinomoto Bio-Pharma Services Introduces AJILITY Fast Track Platform for Drug Product Manufacturing Weiterlesen June 2, 2020 Ajinomoto Bio-Pharma Services Completes Acquisition of Granules OmniChem Joint Venture in India Weiterlesen May 27, 2020 Ajinomoto Bio-Pharma Services Signs Manufacturing Agreement with Humanigen for Lenzilumab, Currently in FDA-Approved Phase III Study for COVID-19 Weiterlesen May 5, 2020 Ajinomoto Bio-Pharma Services Announces Manufacturing Partnership with CytoDyn for Drug Product Used in COVID-19 Clinical Trials Weiterlesen April 30, 2020 Trio Pharmaceuticals, Inc. and Ajinomoto Bio-Pharma Services Enter into a Development Collaboration for a Novel Antibody Therapeutic Weiterlesen March 10, 2020 Ajinomoto Bio-Pharma Services Announces Formation of External Advisory Board Weiterlesen September 2, 2019 Information accompanying the revision of the consumption tax rate Weiterlesen August 29, 2019 Ajinomoto Bio-Pharma Services Acquires Remaining Interest in Granules OmniChem Joint Venture in India Weiterlesen April 9, 2019 Information on Service Brand Name Change Weiterlesen April 9, 2019 GeneDesign Joins Ajinomoto Bio-Pharma Services and Opens Oligonucleotide API Development Center Weiterlesen April 3, 2019 Jean-Baptiste Agnus Joins Ajinomoto Bio-Pharma Services’ Global Leadership Team as Vice President of Sales and Marketing Weiterlesen March 12, 2019 Ajinomoto Bio-Pharma Services Announces Capital Expansion to Fuel Growth Weiterlesen Wird geladen…Mehr laden
